analysis uncovered greater expression at the mRNA level for enzymes reported to function in acetylation and deacetylation as compared to enzymes implicated in glutamylation and deglutamylation. Taken together, the results represent a step toward unraveling the tubulin isotypic expression profile and post-translational modification patterns in astrocytes during human brain development.
Introduction
Tubulin is a ubiquitous cytoskeletal component tasked with supporting a complex array of cellular functions such as chromosomal segregation, intracellular transport, and structural mechanics [1, 2] . The diversity of microtubule (MT) functions are attributed, at least in part, to variants of the tubulin alpha and beta isotypes that are expressed preferentially in differentiated tissues or during particular developmental periods [3, 4] . Additional MT specializations arise from post-translational modifications, commonly including tyrosination, acetylation, glutamylation, and glycation [5] . The heterogeneity of tubulin function conferred by differential isotypic expression patterns and post-translational modifications has been referred to as the 'tubulin code' or 'MT code' [6, 7] . The translation of this code is in its infancy, and the analysis of isotypes and modifications throughout the developmental specification of the organ systems is a subject of elevated interest. In the central nervous system, neuronal tubulin isotypes and post-translational modifications of MTs have received a considerable amount of attention [4, [8] [9] [10] [11] [12] [13] . In particular, there is a growing awareness of the relationship between the tubulin code and neurodegenerative disorders: post-translational modifications affect binding of the Alzheimer's-implicated protein tau, and levels of post-translational tubulin modifications are altered in individuals afflicted with Alzheimer's [11, 13] .
In contrast, tubulin specializations are relatively understudied in astrocytes, the most abundant type of glial cell in the brain. For instance, although the class III β-tubulin isotype (βIII-tubulin) encoded by the TUBB3 gene has long been considered a hallmark of neuronal differentiation, it is only recently that TUBB3 expression has been experimentally confirmed in developing human astrocytes [14, 15] . In mature astrocytes, studies have shown that TUBB3 expression is elicited after injury [16, 17] . βIII-Tubulin is expressed after neoplastic transformation of mature glial cells, such as in astrocytoma/ glioblastoma, and in oligodendromal tumors where it is expressed in tumor phenotypes that resemble migrating oligodendrocyte progenitor cells [18, 19] . These findings imply that βIII-tubulin may signify plasticity in non-neuronal cell types.
Although a few research teams have evaluated tubulin acetylation in astrocytes, the absence of a thorough characterization of post-translational modifications in astrocytic tubulin is a significant obstacle to deciphering the MT code in the central nervous system [20, 21] . In order to contribute to the translation of the tubulin code in glial cells, we evaluated two tubulin posttranslational modifications, acetylation and glutamylation, in the commercially available normal human astrocyte (NHA) primary cell line of embryonic (fetal) origin. Our experimental design relied on immunocytochemical detection with antibodies in the research resource identifiers (RRID) registry and implemented methods to enhance reproducibility [22] . The expression of enzymes associated with acetylation and glutamylation at the mRNA level was confirmed by mining our open-source RNA sequencing data for NHA (GSE81995). Taken together our findings provide insight into the expression of tubulin isotypes and modifications at mid-gestation in human brain development.
Methods

Cell Culture
The NHA (Lonza, CC-2565) cell line was chosen for this study because it is a viable in vitro system for studying the post-translational modifications of tubulin in human neural cells. Moreover, NHA cells are commercially available and can be implemented by any research group for validation and follow-up experiments. Two lots of NHA (#0000412568, #0000514417) were cultured according to methods previously published in an open source journal [15] . All manufacturer specifications were followed except for the omission of gentamicin, because aseptic technique enabled culture of NHA in an antibiotic-free environment. Three experiments were undertaken with two different vendor lots (#0000514417, passage 1, passage 2; lot #0000412568, passage 1). Cells were plated in BD Falcon 4-well chambered slides and cultured for 5 days prior to fixation.
Antibody Selection
βIII-Tubulin was selected as the base target for our comparison of acetylation and polyglutamylation in NHA because studies reported in the primary literature provide evidence that βIII-tubulin is ubiquitously expressed in 100% of human fetal astrocytes [14] . βIII-Tubulin was detected with rabbit anti-βIII-tubulin antibody (Abcam; catalog # ab202519, RRID:AB_2631274). Glutamylation was assessed with the mouse anti-polyglutamylated tubulin antibody (Abcam; catalog # ab11324, RRID:AB_297929) which is reported to detect polyglutamylation of both the α-and β-tubulin isoforms. Acetylation was evaluated with the mouse anti-acetylated tubulin antibody (Sigma-Aldrich; catalog # T7451, RRID:AB_609894) that has been reported to detect the α-isoform.
Antibody Validation
Western blot analyses were used to validate the antibodies with protein isolated from both NHA lots. Cells cultured in T-25 flasks for 5 days were lysed in radioimmunoassay precipitation buffer (50 mM Tris-HCl pH = 8.0, 150 mM sodium chloride, 0.1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate) with supplemented protease inhibitor cocktail diluted at 1:10 (Sigma-Aldrich; catalog # P8340). Protein concentration was determined with the RC DC™ Protein Assay (BioRad; catalog # 5000121). Protein samples (40 µg) were mixed with Laemmli buffer and heated at 70 °C for 10 min. Precision Plus Protein™ WesternC™ Standards (5 µl) were heated at 37 °C for 5 min. Samples and molecular weight markers were analyzed with SDS-PAGE (200 V, 40 min) with 10% Mini-PROTEAN ® TGX Stain-Free™ Protein Gels (BioRad; catalog # 4568034S) and pre-chilled (4 °C) electrophoresis buffer (25 mM Tris pH = 8.3, 192 mM glycine, 0.1% sodium dodecyl sulfate) using a Hoefer™ MiniVE vertical electrophoresis unit. The same unit was used to electrotransfer protein to nitrocellulose with preheated (70 °C) Towbin buffer without methanol (25 mM Tris pH = 8.3, 192 mM glycine), using a modified version (20 V, 25 min) of the protocol as described in [23] . Membranes were probed using the Pierce Fast Western Blot Kit (ThermoFisher Scientific; catalog # 35055) according to the manufacturer's specifications, with overnight primary antibody incubation periods at 4 °C. Data from at least two separate blots were collected for each antibody. The unconjugated version of the rabbit anti-βIII-tubulin antibody (Abcam; catalog # ab52623, RRID:AB_869991) and the mouse anti-acetylated tubulin antibody were used at a 1:1000 dilution, whereas the concentration of mouse anti-polyglutamylated tubulin antibody required a higher concentration (1:250) to detect a signal. Chemiluminescent signals were detected with a Chemidoc XRS (BioRad).
Immunocytochemistry
NHA were labelled in accordance with previously published methods with the following modifications for antibody type and dilutions [15] . PBST containing 1% Bovine Serum Albumin was used to dilute primary antibodies to the following final concentrations: rabbit anti-βIII-tubulin antibody, 1:300; mouse anti-polyglutamylated tubulin, 1:200; mouse anti-acetylated tubulin, 1:200. The primary antibody against βIII-tubulin was incubated simultaneously with either mouse anti-acetylated tubulin or mouse antipolyglutamylated tubulin.
To determine specificity of the βIII-tubulin antibody, 1 µg/ml of the βIII-tubulin synthetic immunizing peptide was incubated with the diluted βIII-tubulin antibody for 1 h at ambient temperature (~26 °C) before incubating overnight in chambered slides. Slides were incubated at 4 °C overnight in a sealed, darkened, humidified chamber with 250 µl of antibody solution in each well. Nonspecific binding of the secondary antibody was assessed by omitting the primary antibody from negative controls. Alexa Fluor ® 594-conjugated goat anti-mouse IgG (Abcam; catalog # ab150120, RRID:AB_2631447) was diluted at 1:500 in PBS with 1% BSA. Hoescht 33342 (0.1 µg/ml) was used to counterstain cell nuclei before mounting slides as described previously [15] .
Confocal Imaging
Confocal images were acquired with an EC Plan-Neofluar ×10/0.3 objective mounted on an inverted LSM 700 microscope (Zeiss). Hoescht 33342 was excited with laser excitation at λ = 405. Alexa Fluor ® 555 and Alexa Fluor ® 594 were excited with laser excitation at λ = 555. The main beam splitter was MBS 405/488/555/639, and the SP 555 filter used to collect emission from all fluorophores. To separate the emission from Alexa Fluor ® 555 and Alexa Fluor ® 594 fluorophores, dichroic beam splitters were used at 559 and 628 nm in the respective channels. All confocal images were captured with identical settings (Table 1) .
Fluorescent Intensity Analysis
The ZenLightEdition software package (Zeiss) (2009) was used to create maximum intensity projections and export files with a .tif extension. The image processing package 'EbImage' for the R statistical programming language was used to import .tif files and translate images into a two dimensional array of pixel intensity values between 0 (black) and 1 (white) using a 16-bit range (2 16 values) [24] . The degree of post-translational modification of tubulin (acetylation or polyglutamylation) was estimated as a ratio of the sum of fluorescent signal from acetylated or polyglutamylated tubulin to the sum of fluorescent signal from βIII-tubulin with intensity signals corrected as described below. The ratio of modified tubulin/βIII-tubulin fluorescent signal was calculated for each image (n = 10 acetylated; n = 10 polyglutamylated). Potential differences in mean values of fluorescence intensity ratios for acetylated and polyglutamylated tubulin to βIII-tubulin were calculated using the student's t test with a p value significance threshold of 0.01.
In order to omit 98% of fluorescent signal that resulted from nonspecific antibody binding, the 98th percentiles of pixel intensities from control images were calculated individually for each image, and averaged separately for both negative control groups (primary antibody against βIII-tubulin blocked with immunizing peptide, secondary antibody with primary omitted). Omission of 98% of the background signal was accomplished by subtracting the aforementioned average value for negative control images from the pixel intensity of the corresponding frames of experimental images (value of controls blocked with immunizing peptide was subtracted from pixel intensity values βIII-tubulin images; value of secondary antibody with primary omitted was subtracted from pixel intensity values for acetylated tubulin or polyglutamylated tubulin).
Pixel intensity values that fell outside the established range from black (0) to white (1) after background subtraction (i.e. below zero) were set at zero prior to calculating the sum of intensity values.
Colocalization
The statistical programming language R was used to estimate colocalization for all pixels in both modified tubulin (1C3, 2C3) and βIII-tubulin (1B3, 2B3) channels corresponding to a single optical section from each condition. Colocalization of signals from post-translationally modified tubulin and βIII-tubulin was evaluated using the Pearson's correlation coefficient, Mander's overlap coefficients, and the Costes randomization coefficient (reviewed in [25] ). A second colocalization analysis was undertaken with the values of the extracellular areas of the image omitted. An extracellular section of approximately 200 × 200 pixels was cropped from each image. The mean extracellular image pixel values were estimated and used as a threshold for normalizing the corresponding images. This analysis was intended to validate the first colocalization analysis by ensuring that the Pearson's correlation coefficient was not inflated due to correlated extracellular regions. Moreover, because both the Mander's and the Costes' approach are sensitive to background signal, omitting the extracellular pixel values strengthens the validity of these analyses. The second colocalization was estimated for the normalized images as described above.
Figure Preparation
Figures were prepared using the statistical programming language R, in conjunction with the 'ggplot2' and 'ggthemes' data visualization packages [26, 27] . Alignment, labelling, and assembly of images were completed with Photoshop (Adobe, CS6). The ZenLightEdition software package (Zeiss) (2009) was used to manipulate the contribution of the fluorescence signal from each channel in order to visualize all signals in the merged confocal images, and to export confocal images as TIFF files. Digital images of western blots were converted to TIFF files and digitally enhanced for contrast using the Auto Scale function in Image Lab software (version 6.0; BioRad).
Compliance with Ethical Standards and Reproducibility Methods
Guidelines for preclinical research set forth by the NIH were used as a model for our experimental procedures [28] . The vendor, Lonza, produced NHA according to national ethics standards, de-identified the cell line, and retains the signed record of informed consent from human donors. The NMSU Institutional Biosafety Committee approved the use of commercially available human cell lines (approval # 1401SE2F0103). De-identified, commercially available human cell lines developed before 2015 are exempt from review by the NMSU Institutional Review Board. The NIH retains a signed copy of the Extramural Institutional Certification form for human cell lines created before January 25, 2015 with the GEO data files previously submitted by our research team (GSE819950).
NHA were used within three passages (ten population doublings) according to the guaranteed vendor specifications. The human origin of the cell line was verified by the vendor, and confirmed in previous RNA sequencing experiments by our laboratory (GSE81995) [15] .
Alexa Fluor ® 555-conjugated rabbit anti-TUBB3 monoclonal antibody (Abcam; catalog # ab202519, RRID:AB_2631274) was validated as described above, by blocking with the immunizing peptide. The unconjugated version of this antibody (ab52623) from the identical clone [EP1569Y] has been validated by the vendor, and previously used to label the NHA cell line [15] . Both the mouse anti-polyglutamylated tubulin antibody (Abcam Cat# ab11324, RRID:AB_297929) and the mouse anti-acetylated tubulin antibodies (Sigma-Aldrich Cat# T7451, RRID:AB_609894) have been validated in previous experiments with murine neural cells [29, 30] . The Alexa Fluor ® 594-conjugated goat anti-mouse IgG (Abcam; catalog # ab150120, RRID:AB_2631447) was Fig. 1 βIII-Tubulin and acetylated tubulin. Confocal microscopy was used to obtain the fluorescence signal from optical section (1-4) . The fluorescent nucleic acid probe Hoescht 33342 (a1-a4) was used in conjunction with immunocytochemical methods that labelled βIII-tubulin (b1-b4) and acetylated tubulin (c1-c4) in normal human astrocytes cultured for 5 days. Scale bar 200 µm. Settings for image capture are described in Table 1 . See Online Resource 1 for color representation of the merged images ◂ validated by assessment of fluorescence when the primary antibodies were omitted.
Results
Immunocytochemical Detection
The characterization of tubulin post-translational modifications in NHA was undertaken using immunocytochemical methods. A positive label for βIII-tubulin was observed throughout optical sections of the cell cultures (Figs. 1, 2 ). This result is congruent with previous findings that report expression of βIII-tubulin in 100% of cultured human fetal astrocytes at the midgestational period [14] . The labelling pattern of acetylated tubulin resembled the labelling pattern of βIII-tubulin (Fig. 1) . In contrast, the labelling pattern for polyglutamylated tubulin represented a smaller portion of the cultured cells than both acetylated tubulin and βIII-tubulin (Fig. 2) . Western blot experiments were consistent with these findings; higher concentrations of antibody were required to detect polyglutamylation in the blots (Online Resource 3).
Evaluation of Fluorescence Intensity
The 'Ebimage' package for the statistical programming language R was used to separate the channels from confocal images and assign each pixel an intensity value ranging from 0 (black) to 1 (white). The ratio of intensity values for post-translationally modified (acetylated or polyglutamylated) tubulin label to βIII-tubulin label was calculated for each image. The mean value of the acetylated tubulin/ βIII-tubulin ratio (0.42) was almost twice as much as the mean value of polyglutamylated tubulin/βIII-tubulin ratio (0.24; Table 2 ). The p value from Student's t test comparing the ratio of acetylated tubulin to βIII-tubulin to the ratio of polyglutamylated tubulin to βIII-tubulin (Table 2) was less than the threshold p value of 0.01 (Table 2) , conferring significance to the findings.
Colocalization Analyses
The degree of colocalization between post-translationally modified tubulin and βIII-tubulin was calculated for the 3rd optical section from Figs. 1 and 2 . Scatterplots of the pixel intensity values from the red (acetylated or polyglutamylated tubulin; x axis) and green (βIII-tubulin; y axis) channels were plotted against one another (Fig. 3) . The pixel intensity values assigned by 'Ebimage' were used to calculate the Pearson correlation coefficient, the Costes randomization coefficient, and the Mander's overlap coefficient with the statistical programming language R.
Colocalization analysis uncovered a high degree of correlation between acetylated tubulin and βIII-tubulin with all three methods (Table 3) . Similarly, a strong correlation was indicated for polyglutamylated tubulin and βIII-tubulin; however, there is an even greater degree of correlation for acetylated tubulin and βIII-tubulin (Table 3) . Thresholding to exclude all pixel values below the mean intensity value from a 200 × 200 extracellular region increased the degree of correlation with the Costes and Mander's techniques, but did not alter the Pearson correlation coefficient. This finding is consistent with the sensitivity to background signal previously reported for these methods [25] .
mRNA Levels of Enzymes with a Putative Role in Acetylation or Glutamylation
RNA sequencing data from NHA (GSE81995) were used to evaluate expression of enzymes that are reported to function as tubulin post-translational modifiers [15] . mRNA expression levels, normalized as fragments per kilobase of exon per million reads mapped (FPKM), were determined for 22 enzymes that are implicated in acetylation/deacetylation and glutamylation/deglutamylation of tubulins (Table 4 ; reviewed in [2, 31, 32] ). Enzymes with very low FPKM levels (below 1) are omitted from Table 4 (tubulin glutamylases, TTLL 2, 6, 9, 13; tubulin deglutamylases, AGBL 1-4). The average FPKM values for enzymes involved in acetylation (~16) and deacetylation (~16) were greater than the average FPKM values for enzymes involved in glutamylation (~2) and deglutamylation (~2).
Discussion
Astrocytes are highly variable in both structure and function, particularly in humans [33] [34] [35] [36] . However, the role of specified and modified tubulins in imparting this diversity is not well documented. This research was an effort to advance the current understanding of tubulin specifications in human fetal astrocyte cultures. Immunocytochemistry and western blot methods were used to label βIII-tubulin, acetylated tubulin, and polyglutamylated tubulin in NHA.
In accordance with previous reports of βIII-tubulin expression in human fetal astrocytes, we observed a prevalent label for βIII-tubulin in normal human astrocyte Fig. 2 βIII-Tubulin and polyglutamylated tubulin. Confocal microscopy was used to obtain the fluorescence signal from optical section (1-4) . The fluorescent nucleic acid probe Hoescht 33342 (a1-a4) was used in conjunction with immunocytochemical methods that labelled βIII-tubulin (b1-b4) and polyglutamylated tubulin (c1-c4) in normal human astrocytes cultured for 5 days. Scale bar 200 µm. Settings for image capture are described in Table 1 . See Online Resource 2 for color representation of the merged images ◂ cultures [14, 15] . Although it is possible that βIII-tubulin expression in cultured NHA may represent a cytoskeletal adaptation of microtubules to in vitro culture conditions, our findings are consistent with the in situ demonstration of βIII-tubulin co-localization with GFAP+ and nestin + immature glial cells in formaldehyde-fixed, paraffin embedded histologic sections of human fetal brain [14] . While βIII-tubulin has had a long-standing role as a neuronal marker, recently it has been recognized as indicative of more plastic cell types, such as immature astrocytes and different types of cancer [14, 18, 19, 37] . Moreover, upregulation of βIII-tubulin has been observed in astrocytes following injury, alluding to a role in neuroglial regeneration [16, 17] . These findings suggest a link between the expression of βIII-tubulin and plasticity, a phenotype that has been previously established in NHA [38] .
Confocal images also demonstrated a positive label for acetylated tubulin and polyglutamylated tubulin in NHA cultures (Figs. 1, 2) . In neurons, acetylation and polyglutamylation have been associated with growth [39, 40] and regeneration [41] , respectively. In glial cells, posttranslational modifications of tubulin have been implicated in functions that include modulating astrocytic Na + K + ATPase activity [20] , and dysfunctions related to the tubulin-associated protein tau [21, 42] . Colocalization analyses revealed a strong correlation between the fluorescence signals from βIII-tubulin and acetylated tubulin, as well as between βIII-tubulin and polyglutamylated tubulin (Table 3 ; Fig. 3 ). Quantification of fluorescence intensity values from confocal images revealed statistically significant differences between fluorescent intensity ratios of acetylated tubulin/βIII-tubulin and polyglutamylated tubulin/βIII-tubulin ( Table 2 ). The larger ratio of acetylated tubulin/βIII-tubulin provides quantitative support of our qualitative visual observations. A similar pattern can be observed in our western blot analyses of acetylation and polyglutamylation (Figs. S1B, S1C) .
Recent interest in post-translational modifications of glial cells has prompted investigation of this process in Schwann cells. Gadau (2010) characterized relative amounts of several modified tubulins and found that polyglutamylation occurs at a significantly higher level than acetylation in an immortalized rat Schwann cell line [43] . In contrast, we found that levels of polyglutamylation are significantly lower than acetylation in NHA. Gadau speculated that the increase in polglutamylation that they observed could be due to the antibody binding to both the α-and β-tubulin isotypes. Although we used the same antibody in our studies, we observed a decreased intensity of signal for polyglutamylation as compared to acetylation in NHA. The marked difference in relative abundance of acetylation and polyglutamylation in cultured, primary human astrocytes as compared to immortalized rat Schwann cells warrants downstream investigation of the function of acetylation and polyglutamylation in glial cells and the potential role of the tubulin code in the specification of glial cell fate.
We reasoned that detection of post-translational tubulin modifications at the protein level implied the presence of specific modifying enzymes in NHA. We predicted that by mining RNA sequencing data for NHA (GSE819950), we should be able to identify transcripts for enzymes involved in the addition and removal of acetyl and glutamyl side chains. As expected, mRNA expression values were greater than 1 FPKM for 14 of 22 enzymes implicated in acetylation/deacetylation and glutamylation/deglutamylation of tubulins (Table 4 ; reviewed in [31, 32] ). The greater FPKM expression values for enzymes involved in acetylation (~16) and deacetylation (~16) as compared to enzymes involved in glutamylation (~2) and deglutamylation (~2) support the premise that acetylation is more prevalent than polyglutamylation in NHA. However, the amount of post-translational modification also depends on enzymatic activity. Therefore, additional studies are needed to link the amount of post-translational modification of tubulin with the expression levels of the enzymes conferring the modifications.
In mature murine brain tissue, the deacetylating enzymes HDAC6 and SIRT2 are expressed in Purkinje cells and oligodendrocytes, respectively, but not astrocytes [44] . In contrast, RNA-seq data from cultured NHA show that SIRT2 and HDAC6 are expressed in the mRNA of human fetal astrocytes, and our detection of the acetylated tubulin protein implies the presence of acetylating and deacetylating enzymes in NHA. The observation that SIRT2 and HDAC6 are expressed in human fetal astrocyte mRNA, but not mature mouse astrocytes, suggests that the expression of these enzymes in astrocytes may be restricted to an immature developmental time point, or may be species-specific. In summary, these experiments profiled isotypic expression and post-translational modification patterns of tubulin in human fetal astrocytes. Quantification of fluorescence intensity values from immunocytochemical probes revealed a greater proportion of acetylated tubulin than polyglutamylated tubulin, though both modifications were detectable at the protein level. This trend was supported by data from our western blot experiments and our analysis of RNA-seq experiments with cultured NHA (GSE81995). Results from these experiments illuminate the complexity of expression patterns and modifications of tubulin in human fetal astrocytes, and accentuate the need to explore how the tubulin code contributes to the determination of glial identity in the developing nervous system. 
